The pathophysiology of hypertension in patients with obesity. - Test2 - elhamkhani - TriplyDB

The pathophysiology of hypertension in patients with obesity.

The pathophysiology of hypertension in patients with obesity.

http://www.wikidata.org/entity/Q35021492

about

Caloric Restriction as a Strategy to Improve Vascular Dysfunction in Metabolic Disorders Pathogenesis of Cardiovascular and Metabolic Diseases: Are Fructose-Containing Sugars More Involved Than Other Dietary Calories?Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy Vascular stiffness in insulin resistance and obesity The great roundleaf bat (Hipposideros armiger) as a good model for cold-induced browning of intra-abdominal white adipose tissue Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.Association between prevalence of hypertension and components of metabolic syndrome: the data from Kailuan community.The effect of acute maximal exercise on postexercise hemodynamics and central arterial stiffness in obese and normal-weight individuals.Diabetic cardiomyopathy: where we are and where we are going.Obesity-Induced Hypertension: Brain Signaling Pathways.Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western Diet.Obesity-induces Organ and Tissue Specific Tight Junction Restructuring and Barrier Deregulation by Claudin Switching Overnutrition, mTOR signaling, and cardiovascular diseases.Leptin signaling molecular actions and drug target in hepatocellular carcinoma Obesity, albuminuria, and gamma-glutamyl transferase predict incidence of hypertension in indigenous Australians in rural and remote communities in northern Australia Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice Abdominal Adipose Tissue was Associated with Glomerular Hyperfiltration among Non- Diabetic and Normotensive Adults with a Normal Body Mass Index Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.Acupoint massage nursing conducive to improve curative effect of the obesity patients who are complicated with hypertension and are treated by oral drugs.Systemic PPARγ deletion causes severe disturbance in fluid homeostasis in mice.Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.Weight Status and Blood Pressure among Adolescent African American Males: The Jackson Heart KIDS Pilot Study Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females Salt Sensitivity in Response to Renal Injury Requires Renal Angiotensin-Converting Enzyme Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study.Bombesin-like receptor 3 regulates blood pressure and heart rate via a central sympathetic mechanism Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice.Genetic variability to diet-induced hippocampal dysfunction in BXD recombinant inbred (RI) mouse strains.Immune Profile of Obese People and In Vitro Effects of Red Grape Polyphenols on Peripheral Blood Mononuclear Cells.7th Brazilian Guideline of Arterial Hypertension: Chapter 6 - Non-pharmacological treatment Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance.The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.

P2860

Q26744463-0AB26B93-891B-4739-B041-31F542769E60 Q26749148-A8FDE451-0B25-4608-9040-AE6E20AE65AC Q26765175-4E035AAE-B303-45A0-943A-6B0B72F1FB54 Q26774779-691ABF9A-89C5-4B26-A497-A95B582D523B Q26775037-E7A3160A-75C2-46F7-A1B1-7FE72E683D7B Q26796220-A153D397-CCE7-4FE2-B96D-AEBD8FE721CA Q28652249-9546D407-C6E5-41DF-BD61-EFD3050DA0CA Q30234618-A389509B-7617-4248-9E4B-1F433683A6AD Q30856824-AA930568-6AC0-463A-BDEC-AB42BFFE32A0 Q33567503-AA32E341-03B9-46D2-A6F3-7F643BD05531 Q33690717-F5DD78F9-FF16-4E71-8113-C5DDAC55F92F Q33739338-9CD38AA9-4936-402E-A621-ECFD7F26B202 Q33856877-16AEBD84-BC13-489A-ACEF-99E14816C9E9 Q33894841-DB35245C-DFC1-44B1-81ED-A1BCF69DB6DA Q34519316-7521AFC1-2D8E-4BF0-8D19-A11638462E84 Q34548342-9BC42806-D68A-4A3A-80AA-DDD93CCAC810 Q35161739-23726C92-E7DC-4C9C-8323-8F4F58293A5D Q35186358-950706CD-D148-407A-953F-18139EA5E6B4 Q35208175-05858697-183A-4379-B030-ED2ABC31FF2C Q35592620-390457F2-5537-4213-B34C-E5C9CF9406BD Q35738015-3AFC34CE-A1CC-48DF-BE6B-99C5BD674EBF Q35818630-39BDF830-A4DD-4F2A-B786-5C9A500F63CC Q35958750-7B5E6D56-0A2E-4A28-9DDB-11B61207B97C Q36046951-938C85EB-3CCA-4628-B293-2081BE93C9B5 Q36237301-1CD5453F-415D-400B-B9C5-796C2EFC2666 Q36277736-A7E43195-FF3E-4E8A-812F-9AEB8590344E Q36351394-A746FA12-7AF4-4072-BC5B-691BEE3684DC Q36485459-5CB003BA-79AD-48AD-9FC9-E2D94E0268B1 Q36703486-4CFC5B34-93E8-44FB-9701-08AFEB7C2FFE Q36780988-62566A65-A878-43CA-B55B-941DA9AEBAC0 Q36822591-35EB0F97-0C92-49CA-97EF-6EB503EB94C7 Q36895790-DC70698E-8F45-4EF0-96F9-D32DC59CC110 Q37080167-EB6CA80C-1431-467B-8D36-64290053115B Q37580106-3EA05EF1-96A3-44D6-8B37-80A33D4B3888 Q37627562-24877D77-928D-4E88-AA0E-8B4F402AACC3 Q37656197-539EBED8-893C-41D8-BBD3-824F65F45063 Q38648316-01BD6B01-767A-47AC-83FA-79F8A374006F Q38871976-A791BBCD-ABF4-44D4-953F-F334519B886A Q38901721-6F884D19-8735-4B81-BFFC-8412A6918D7B Q39018887-27130BAD-7239-4C56-8F6B-522196D6EF2D

P2860

The pathophysiology of hypertension in patients with obesity.

http://www.wikidata.org/entity/Q35021492

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The pathophysiology of hypertension in patients with obesity.

@ast

The pathophysiology of hypertension in patients with obesity.

@en

type

label

The pathophysiology of hypertension in patients with obesity.

@ast

The pathophysiology of hypertension in patients with obesity.

@en

prefLabel

The pathophysiology of hypertension in patients with obesity.

@ast

The pathophysiology of hypertension in patients with obesity.

@en

P1433

Q35021492-A9F389DD-9443-4EBE-BBE4-065087062B75

P1476

Q35021492-6A7B0E4F-E3A1-402D-97D5-720D6643F285

P2093

Q35021492-76ABCFD9-9A3E-4DCD-A7DC-2B169049FD44

Q35021492-CA742B36-BF16-4C5A-95E6-1D86BB30259D

P2860

Q35021492-0351D65C-90F3-47CD-9B19-F5A67F5190DF

Q35021492-0589F197-E9FB-4582-9801-BAEB1316D802

Q35021492-05F15251-4DEF-41FF-ADFB-9F33246F843B

Q35021492-0617A1EC-5248-4045-BEB9-F065FCD81C96

Q35021492-06551A71-49B7-4740-9BC5-48124D91AEDF

Q35021492-07234359-F8CC-4875-9EB4-0EB670EBFE5D

Q35021492-098D4080-3601-4BD6-BD8B-120B90BE55EC

Q35021492-0D1B3C5A-CA63-412A-B3F0-C3770EE6F56D

Q35021492-0E146BBF-5405-416B-8160-675C061A1E75

Q35021492-11ADC095-FEA5-4F4C-A929-F58290719610

P2888

Q35021492-2791A88C-AC28-46CD-91A5-9322AC76203F

P304

Q35021492-20AD0AC0-23E5-4CB2-81FA-434773811444

P31

Q35021492-E2516CB9-B394-4A01-8FD3-A32FF9D92450

P356

Q35021492-AAB4D87A-4C85-4ABB-A336-F2351BE0027A

P433

Q35021492-AE452647-9428-4B76-BF10-A090C1388A51

P478

Q35021492-625A20AF-F833-4983-985E-F9645AC597FD

P50

Q35021492-85590BD4-1E79-4DAD-B339-BA20D8A0D156

P577

Q35021492-595D4373-8081-428A-9B0F-2B3667E6ED05

P698

Q35021492-0105A703-9488-4C1C-8501-83C020F15C51

P921

Q35021492-40C494AC-F537-4A6B-835B-3DBF849D449B

Q35021492-76612A75-253B-491F-8724-6EA255BCA95D

Q35021492-CC0D7A77-ADF5-421B-B229-B2E018B930E5

P932

Q35021492-AA01B8F5-BEC4-4429-A702-59DEC828A769

P356

P1433

Nature Reviews Endocrinology

P1476

The pathophysiology of hypertension in patients with obesity.

@en

P2093

Annayya R Aroor

http://www.w3.org/2001/XMLSchema#string

James R Sowers

http://www.w3.org/2001/XMLSchema#string

P2860

Putative contributors to the secular increase in obesity: exploring the roads less traveled

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

A novel adipokine CTRP1 stimulates aldosterone production

Obesity alters gut microbial ecology

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

Ten putative contributors to the obesity epidemic

Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group

Nitric oxide: physiology, pathophysiology, and pharmacology

The influence of perivascular adipose tissue on vascular homeostasis

The sympathetic nervous system in obesity hypertension

P2888

P304

364-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRENDO.2014.44

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Vincent G DeMarco

P577

2014-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24732974

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

4308954

http://www.w3.org/2001/XMLSchema#string